Legacy Health
Approved Hospital Formulary
Pharmacy - Home (sharepoint.com)
Contact Pharmacy
Search by name
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
RCRA
Do Not Crush
Black Box Warning
REMS
Restricted
Legacy Hazardous Drugs
Do Not Tube List
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
Boards
Report an iCare
Legacy Health
Approved Hospital Formulary
Pharmacy - Home (sharepoint.com)
Contact Pharmacy
Search by name
Additional search options
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
RCRA
Do Not Crush
Black Box Warning
REMS
Restricted
Legacy Hazardous Drugs
Do Not Tube List
Search results for:
glecaprevir-pibrentasvir
glecaprevir-pibrentasvir
Drug Name
Form
Strength
Notes
Mavyret
PELLET, ORAL
50 mg-20 mg
Mavyret
TABLET, ORAL
100 mg-40 mg
VIEW MORE
HCV Protease Inhibitors
,
HCV Replication Complex Inhibitors
CLASS
08184020
,
08184024
Additional Information:
NON-formulary medication
Last updated:
Feb. 23, 2023
Black Box Warning:
Risk of Hepatitis B Virus Reactivation in Patients Coninfectd with HCV and HBV
Micromedex
CareNotes
UpToDate
Facts & Comparisons
MedLinePlus (Patient Information)
Add Formweb to your mobile device
NON-formulary medication